Get started
Author

Kevin Carroll

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 · Nick Thatcher, Alex Chang, et al. · The Lancet · 2,081
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
2011 · Kenneth W. Mahaffey, Daniel M. Wojdyla, et al. · Circulation · 435
PDF
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
2019 · Aliza Thompson, Kevin Carroll, et al. · Clinical Journal of the American Society of Nephrology · 320
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
2021 · Ajay K. Singh, Kevin Carroll, et al. · New England Journal of Medicine · 234
PDF
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients
2022 · Ajay K. Singh, Borut Cizman, et al. · JAMA Internal Medicine · 78
PDF
Optimizing randomized phase II trials assessing tumor progression
2006 · Andrew Stone, Catherine Wheeler, et al. · Contemporary Clinical Trials · 23
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
2021 · Ajay K Singh, Allison Blackorby, et al. · Nephrology Dialysis Transplantation · 19
PDF
On the need for increased rigour and care in the conduct and interpretation of network meta‐analyses in drug development
2016 · Kevin Carroll, Robert Hemmings · Pharmaceutical Statistics · 17
Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective
2020 · Sarah Dewilde, Kevin Carroll, et al. · Cost Effectiveness and Resource Allocation · 16
PDF
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials
2022 · Ajay K Singh, Finnian R McCausland, et al. · Nephrology Dialysis Transplantation · 14
PDF
PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomized, Active-Controlled Trial
2010 · Patrick Peterson, Kevin Carroll, et al. · Statistics in Biopharmaceutical Research · 14
Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials
2022 · A K Singh, A Acharya, et al. · European Heart Journal · 10
PDF
The ASCEND-ND trial: study design and participant characteristics
2021 · Vlado Perkovic, Allison Blackorby, et al. · Nephrology Dialysis Transplantation · 10
PDF
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease
2022 · Finnian R Mc Causland, Ajay K Singh, et al. · New England Journal of Medicine · 7
#1021 A phase 3 randomized controlled trial of ravulizumab in adult patients with IgA nephropathy
2024 · Hernán Trimarchi, Jonathan Barratt, et al. · Nephrology Dialysis Transplantation · 6
PDF
Conditional approval: discussion points from the PSI conditional approval expert group
2007 · Kevin Carroll, Hilary Chaudri Ross, et al. · Pharmaceutical Statistics · 6
Current Fluorescence-Guided Platforms and Devices
2023 · Donovan Hui, Kevin Carroll, et al. · Springer eBooks · 4
Mo246estimating Delay in Time to Eskd for Treatment Effects on Proteinuria in Iga Nephropathy and Fsgs*
2021 · Kevin Carroll, Leah Conley, et al. · Nephrology Dialysis Transplantation · 4
PDF
Investigation of mixed model repeated measures analyses and non‐linear random coefficient models in the context of long‐term efficacy data
2018 · Bruno Delafont, Kevin Carroll, et al. · Pharmaceutical Statistics · 4
Literature Review October–December 2008
2009 · Kevin Carroll, S. Krishna Padmanabhan, et al. · Pharmaceutical Statistics · 4
Design and analysis of non‐inferiority mortality trials in oncology
2004 · Kevin Carroll, Bob Milsted, et al. · Statistics in Medicine · 4
Three Cases of Local Anesthetic Systemic Toxicity following regional infiltration analgesia: The need for prompt recognition and treatment
2023 · Kevin A. S. Carroll, Jonathan Henglein, et al. · Journal of Anesthesiology and Pain Therapy · 3
PDF
#4503 Estimating Delay in Time to Kidney Failure or Death for Treatment Effects on Proteinuria in Iga Nephropathy
2023 · Alex Mercer, Kevin Carroll, et al. · Nephrology Dialysis Transplantation · 3
PDF
Literature review April–June 2008
2008 · Scott D. Patterson, Kevin Carroll · Pharmaceutical Statistics · 3
Farabursen Increases Urinary Polycystin-1 and Polycystin-2 and Reduces Height-Adjusted Total Kidney Volume Growth in Patients with ADPKD
2025 · Alan S.L. Yu, Rekha Garg, et al. · Journal of the American Society of Nephrology · 2
Works count: 53
Citation count: 3,333
H-index: 11
I10-index: 13
Year
Topic
Type